MENU
+Compare
SNOA
Stock ticker: NASDAQ
AS OF
Oct 8, 04:59 PM (EDT)
Price
$4.13
Change
-$0.12 (-2.82%)
Capitalization
6.88M

SNOA Sonoma Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States... Show more

SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNOA with price predictions
Oct 07, 2025

SNOA in -1.80% downward trend, declining for three consecutive days on October 02, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SNOA declined for three days, in of 371 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for SNOA crossed bearishly below the 50-day moving average on September 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

SNOA broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNOA entered a downward trend on October 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where SNOA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 06, 2025. You may want to consider a long position or call options on SNOA as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SNOA just turned positive on October 07, 2025. Looking at past instances where SNOA's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

SNOA moved above its 50-day moving average on October 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SNOA advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SNOA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.696) is normal, around the industry mean (18.744). P/E Ratio (0.000) is within average values for comparable stocks, (73.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.989). SNOA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.402) is also within normal values, averaging (47.108).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNOA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of prescription and non-prescription products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
5445 Conestoga Court
Phone
+1 800 759-9305
Employees
171
Web
https://www.sonomapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HP23.730.06
+0.25%
Helmerich & Payne
EMA48.130.09
+0.19%
Emera Inc
PZG1.25N/A
N/A
Paramount Gold Nevada Corp
TATT42.87-1.11
-2.51%
TAT Technologies Ltd
WOK0.07N/A
-4.10%
WORK Medical Technology Group Ltd

SNOA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNOA has been loosely correlated with DRRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SNOA jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-3.41%
DRRX - SNOA
39%
Loosely correlated
N/A
BNXTF - SNOA
29%
Poorly correlated
+2.58%
BGLAF - SNOA
27%
Poorly correlated
N/A
AKAN - SNOA
25%
Poorly correlated
-15.47%
CRDL - SNOA
25%
Poorly correlated
-1.85%
More

Groups containing SNOA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-3.41%
Pharmaceuticals: Generic
industry (222 stocks)
19%
Poorly correlated
+0.57%